vstipuslapis@gmail.com

Grant agreement number: (no. 13.1.1-LMT-K718-05-0023) Aim of the project: Project aimed to expand applied knowledge and develop a digital tool for assessment of changes in the rate of evolution of emerging SARSCoV-2 lineages and the potential impact of new virus lineages on immune vaccine efficacy) and clinical response, through the implementation of high-level scientific research project in […]

Grant agreement number: (no. 09.3.3-LMT-K-712-01-0130) Aim of the project: To determine the profile of circulating genetic, epigenetic and blood-derived microbiome biomarkers in gastric cancer and precancerous gastric conditions and evaluate the suitability of these biomarkers for noninvasive diagnosis, monitoring and prognosis of the diseases. Source of funding: EU Structural Fund

Grant agreement number: r (no. 01.2.2-LMT-K-718-03-0086) Aim of the project: Project aims to develop a multicomponent molecular test for non-invasive colorectal cancer screening, through the implementation of the innovative world-class project in the field of Natural Sciences, Source of funding: EU Structural Fund

Grant agreement number: (no. S-BMT-21-9 (LT08-2-LMT-K-01-041)) Aim of the project: By using in vitro and in vivo models, including patientderived xenografts, project aimed to evaluate the potential of AHR inhibition in PC therapy, assess the activities of AHR and ELAVL1 pathways in PC patients, to determine the subsets of patients who would benefit most from AHR inhibition,

Grant agreement number: (no. S-BMT-21-11 (LT08-2-LMT-K-01-060)) Aim of the project: Project aimed to determine circulating blood microbiome signatures in inflammatory bowel and related autoimmune liver diseases by implementing advanced collaborative multidisciplinary research project betweenNorwegian and Baltic States research institutions. Source of funding: European Economic Area (EEA) (Iceland, Liechtenstein, Norway) Financial Mechanism 2014-2021

Grant agreement number: (no. 01.2.2-CVPA-K-703-02-0013) Aim of the project: The project aimed to develop and test novel personalized gut microbiome modification methods through advanced molecular technologies. Source of funding: EU Structural Funds

Grant agreement number: (no. 01.2.2-LMT-K-718-04-0003) Aim of the project: Project aimed to develop an intestinal organoid model with an inflammatory immune microenvironment, conduct drug testing study for the selection of personalized IBD treatment, and to create an openaccess database based on the phenotypic and molecular data of the patients, organoid and response to treatment. Source of funding: EU